亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會(huì)員登錄|免費(fèi)注冊(cè)|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會(huì)員第1年

成都云希化工有限公司  

美容肽,多肽,美容原料,定制肽,醫(yī)藥中間體

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
聯(lián)系方式
  • 聯(lián)系人:陳
  • 電話:19150309904
  • 郵件:aileen@youngshechem.com
  • 微信:19150309904
  • QQ:1398029096
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應(yīng)產(chǎn)品 > 3-乙酰基-β-蛻皮甾酮 22961-68-8
3-乙酰基-β-蛻皮甾酮 22961-68-8
單價(jià) 10.00 / g對(duì)比
銷量 暫無
發(fā)貨 四川成都市付款后3天內(nèi)
庫存 1000g起訂1g
品牌 成都云希
CAS號(hào) 22961-68-8
純度 ≥98%
外觀 白色粉末
過期 長期有效
更新 2021-07-29 16:43
 
詳細(xì)信息

20-Hydroxyecdysone 3-acetate /β-Ecdysone 3-acetate

3-O-Acetyl-20-hydroxyecdysone

3-乙酰基-β-蛻皮甾酮

Products Name: 20-Hydroxyecdysone 3-acetate /β-Ecdysone 3-acetate

Cat NO.: BP0237

CAS NO.:22961-68-8

Appearance: White Powder

Formula: C29H46O8

Mol Weight:522.679

Botanical Source:Cyanotis arachnoides C.B.Clarke

Purity: 95%~99%

Analysis Method: HPLC-DAD or/and HPLC-ELSD

Identification Method: Mass, NMR

Packing: Brown vial or HDPE plastic bottle

Storage:-2-8,Cool and dry place,Keep away from strong sunlight

Production Ability:Can be supplied from milligrams to grams and please inquire for bulk scale.

Remark:In case of quality issues, please contact us within 15days after received of products.

©2025 成都云希化工有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:41397  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |